Advertisement

Innate Immunotherapeutics Limited Company Profile

15:52 EDT 18th May 2013 | BioPortfolio

Innate Immunotherapeutics Limited is a public unlisted biopharmaceutical company based in Auckland, New Zealand. The company is focused on the development of a new generation of immune response modifiers for potential use in the treatment of MS and other autoimmune diseases, a range of infectious diseases, certain cancers, and as a novel cellular and humoral adjuvant. For further information on the company, please visit our website at http://www.innateimmuno.com.


News Articles [ 256 Associated News Articles listed on BioPortfolio]

Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development

FREDERICK, Md., Aug. 27, 2012 /- Vaccinogen, Inc. today announced Dr. Michael G. Hanna, Jr., Vaccinogen CEO and co-founder, has served as guest-editor and contributor for the Human Vaccines & Imm...

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on can...

New Zealand's Innate Biopharma Reports Phase II Success With MS Drug

Innate Immunotherapeutics of New Zealand reports a Phase II trial of its MIS416 multiple sclerosis drug demonstrated positive results and will move to Phase III trials in Australia. The drug for peopl...

Cancer Researchers Highlight Gating Factors In The Success Or Failure Of Novel Cancer Vaccines

In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on can...

The history of Toll-like receptors — redefining innate immunity

The past 15 years have seen a breakthrough in the field of innate immunity. In this Timeline article, the authors discuss the early events that led to the identification of Toll-like receptors as the...

Positive interim data for Immunotherapeutics' MIS416 in chronic progressive MS

Innate Immunotherapeutics, based in Auckland, New Zealand, said that its lead compound, MIS416 – from its proprietary immune modulating microparticle technology - showed positive Phase I/II inte...

Positive interim data from Innate MIS416 Phase 1/2 clinical trial for chronic progressive MS

Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).

Regulation of innate and adaptive immunity by Notch

Notch signalling has well-described roles in lymphocyte development. More recently, it has become apparent that Notch is also crucial for innate immune cells and for mature lymphocyte responses. Here,...

Drugs and Medications [0 Results]

None

PubMed Articles [ 397 Associated PubMed Articles listed on BioPortfolio]

Innate immune sensing of cancer: clues from an identified role for type I IFNs.

A subset of patients with a variety of cancers shows evidence of a natural adaptive immune response against their tumor, as evidenced by spontaneous T-cell infiltration, circulating anti-tumor T cells...

Innate immunity in the control of HIV/AIDS: recent advances and open questions.

From the publication of the first AIDS issue onwards, major advances have been made in the field of innate immunity during HIV infection. Innate immunity can be defined as the first and unspecific lin...

Innate immunity in the central nervous system.

Immune responses in the CNS are common, despite its perception as a site of immune privilege. These responses can be mediated by resident microglia and astrocytes, which are innate immune cells withou...

Innate-like lymphocytes: An antifungal role for innate lymphoid cells.

Innate immunity: The function of innate lymphoid cells in the lung.

Clinical Trials [ 41 Associated Clinical Trials listed on BioPortfolio]

In Vivo Effects of C1-Esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

Excessive inflammation is associated with tissue damage caused by over-activation of the innate immune system. This can range from mild disease to extreme conditions such as multiple organ...

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Innate immunity plays an important role for fungal recognition and initiation of fungicidal activity. We hypothesize that subtle differences in different molecules of innate immunity may...

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Innate immunity plays an important role for fungal recognition and initiation of fungicidal activity. We hypothesize that subtle differences in different molecules of innate immunity may...

Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients

We hypothesize that ongoing and more severe airway inflammation in COPD may result from the impairment in activation of innate immune response

Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations

The purpose of this study is to determine whether there is a statistical association between the changes from baseline in the levels of two cytokines interleukin (IL)-17A and IL-6 in the s...

Companies [ 48 Associated Companies listed on BioPortfolio]

Innate Immunotherapeutics Limited

Innate Immunotherapeutics Limited is a public unlisted biopharmaceutical company based in Auckland, New Zealand. The company is focused on the development of a new generation of i...

Innate Pharmaceuticals AB

Innate Pharmaceuticals' business concept is to develop bactericidal drugs that meet important medical needs and for which there is a large market. Our business is based on groundbreaking research find...

Innate Immune, Inc.

Innate Immune, Inc. is a privately held biotechnology company focused on the discovery and development of drugs that modulate the activity of natural killer T cells for the treatm...

Artielle ImmunoTherapeutics

OncoMab™ GmbH

OncoMab™ GmbH's business is the development of human antibodies for the treatment of cancer. The OncoMab™ way is unique because the antibodies are not developed in mice or by genetic engineering,...

More Information about "Innate Immunotherapeutics Limited" on BioPortfolio

We have published hundreds of Innate Immunotherapeutics Limited news stories on BioPortfolio along with dozens of Innate Immunotherapeutics Limited Clinical Trials and PubMed Articles about Innate Immunotherapeutics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innate Immunotherapeutics Limited Companies in our database. You can also find out about relevant Innate Immunotherapeutics Limited Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement